← Open Payments lookup

OVAIS KHALID: Open Payments

NPI 1033345954 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,327 in 65 payments from 13 companies in 2025. Trend: 2023 $583 · 2024 $629 · 2025 $1,327

Food & beverage: $1,300Education: $27
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.13$297
ABBVIE INC.16$286
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$211
Otsuka America Pharmaceutical, Inc.5$107
Lundbeck LLC5$95
Vanda Pharmaceuticals Inc.3$94
Axsome Therapeutics, Inc.3$59
Janssen Pharmaceuticals, Inc2$45
Takeda Pharmaceuticals U.S.A., Inc.2$38
Neurocrine BioSciences, Inc.2$37

Products named: COBENFY, VRAYLAR, CAPLYTA, REXULTI, HETLIOZ, Auvelity, ABILIFY ASIMTUFII, ABILIFY MAINTENA.

Industry payments across MD — which companies pay providers there.